Tag: pharmaceuticals
-
Gates Funding Covid-19 Vaccine Delivery Device
A biotechnology company developing a vaccine for the Covid-19 virus received funding to scale up a delivery device for the vaccine when it’s available.
-
Engineered Viruses Deployed to Treat Gut Infections
Academic and industry researchers created gene-editing viruses that in lab cultures and mice killed bacteria causing often deadly intestinal infections.
-
Biotech Partners for A.I. Drug Discovery in $1B Deal
Two companies are collaborating on the use of artificial intelligence to find new drugs addressing a set of proteins that regulate immune-related functions, including inflammation.
-
Business-Foundation Alliance Funds Covid-19 Treatments
Two foundations and a credit card company are providing seed money for development and manufacture of treatments for the novel coronavirus or Covid-19 pandemic.
-
Venom-Aided Immunotherapy Designed for Brain Tumors
Cancer researchers developed engineered immune-system cells, helped by peptides from scorpion venom, that in lab mice bind more reliably to brain tumor cells.
-
Patient Receives First Crispr Genetic Eye Treatment
An individual with a rare genetic eye disease received the first dose of an edited gene in a clinical trial of an experimental treatment for the disorder.
-
Foundation Supports ALS Inflammation Treatments
A foundation is funding a biotechnology company’s research on therapies to block proteins encouraging neuron inflammation in people with amyotrophic lateral sclerosis, or ALS.
-
Infographic – U.S. Having Bad Flu Season
According to data from the Centers for Disease Control and Prevention, the infection rate for this year’s seasonal influenza is among the highest in the past five years.
-
Enrollment Completed in Aging Frailty Stem Cell Trial
A company developing stem cell treatments to counter frailty in older people finished enlisting participants in a clinical trial testing its therapies.
-
Engineered Bacteria Deliver Cancer Immunotherapy
13 Feb. 2020. A biomedical engineering team designed probiotic bacteria, which in lab mice are shown to deliver and enhance cancer immunotherapy drugs. Researchers at Columbia University in New York describe their engineered bacteria and findings in yesterday’s issue of the journal Science Translational Medicine (paid subscription required). Treatments that invoke the immune system to…